Skip to content
NeoVirTech
 
  • Home
  • About
  • Services
    • Virology
    • Oncolytic viruses
    • Disinfection testing
    • Drug discovery
    • Imaging
    • Bespoke service
  • Technologies
    • Anchortm solution
    • Virus collection
    • Imaging platform
  • News
  • Contact
×
  • Home
  • About
  • Services
    • Virology
    • Oncolytic viruses
    • Disinfection testing
    • Drug discovery
    • Imaging
    • Bespoke service
  • Technologies
    • Anchortm solution
    • Virus collection
    • Imaging platform
  • News
  • Contact
 
SCOV2-dsRNA488-NP594-G11-20x-d_H11f03_RGB38
Infected human cells
Human cells infected with SARS-CoV-2 anf fixed 24h post infection. Nucleoprotein in red, SARS-CoV-2 RNA in green. Image acquired on a CellInsight CX7 HCS microscope.
Screenshot-2020-01-22-at-14.21.24
Cancer cells
Cancer cells infected with TG6002 ANCHORTM vaccinia virus (red), fixed and processed for immunofluorescence against LaminB (green). Nuclei counterstained with DAPI. Image acquired on a Zeiss Axiovert Z1
ad5
Human cells
Human cells expressing USP7-mCherry (red) and infected with hAdv5-ANCHORTM (green) and imaged in live 24h post infection. Early (left) and late (right) replication state can be visualized. Image acquired on a Zeiss Axiovert Z1.
Composite 40207
Infected Human cells
Human cells infected with hCMV ANCHORTM (green) fixed and stained with DAPI. Image acquired on a CellInsight CX7 HCS microscope.
 

Follow us

Twitter Linkedin
 
NeoVirTech
  • Home
  • About
  • Services
    • Virology
    • Oncolytic viruses
    • Disinfection testing
    • Drug discovery
    • Imaging
    • Bespoke service
  • NeoVirTech
  • Technologies
    • Anchortm solution
    • Virus collection
    • Imaging platform
  • News
  • Contact
×
  • Home
  • About
  • Services
    • Virology
    • Oncolytic viruses
    • Disinfection testing
    • Drug discovery
    • Imaging
    • Bespoke service
  • Technologies
    • Anchortm solution
    • Virus collection
    • Imaging platform
  • News
  • Contact
NeoVirtech prélèvement
  • Posted on 6 mai 2024
  • In Press release

NeoVirTech will be present at the Eurosatory meeting

NeoVirTech will be present at the Eurosatory meeting, the global event for defence and security.

Come and meet us at Hall5a to discuss MCM development and disinfection testing

Eurosatory Banner

Recommended Posts

Creation of a platform dedicated to oncolytic viruses
NeoVirTech and VirexpR have joined forces to develop an experimental test bench model of airborne contamination by poxviruses
March 2024, NeoVirTech obtains funding from the AAP France 2030 to develop innovative theranostic platform for cancer virotherapies
NeoVirTech SAS and VirexpR SAS create a strategical alliance to combine NeoVirTech’s autofluorescent viruses with VirexpR nebulization technologies for airborne disinfection testing.
About

Beyond virology, breakthrough technology to discover tomorrow's antivirals

  • 1, Place Pierre Potier, Oncopole
    31106 Toulouse FRANCE
  • contact@neovirtech.com
Get in touch

©2021 ComScience – Credits et legal notice – Privacy policy

We use cookies to give you the best experience on our site.

You can find out more about which cookies we are using or switch them off in .

NeoVirTech
Summary of privacy policy

This site uses cookies. Cookie information is stored in your browser and performs functions related to website traffic measurement, font loading. The cookies used on this site are only intended for audience measurement and are completely anonymised (hash rule).

The use of the contact form and its acceptance implies that the interlocutor agrees that his message shoulb be store by NeoVirTech agents in charge of its processing. All emails sent via this form are kept for the time required to process the request and can be deleted on request by email or via the contact form.

Cookies strictement nécessaires

Cette option doit être activée à tout moment afin que nous puissions enregistrer vos préférences pour les réglages de cookie.

Si vous désactivez ce cookie, nous ne pourrons pas enregistrer vos préférences. Cela signifie que chaque fois que vous visitez ce site, vous devrez activer ou désactiver à nouveau les cookies.